Insider · CIK 0001511901

Broadfin Capital, LLC

CIK 0001511901 Name as filed on the most recent filing

Filed as Broadfin Capital, LLC (33)

125 transaction lines · from 33 filings · filed 2014-07-23 to 2021-11-22 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-11-19 P, Open-market purchase Biodelivery Sciences International IncBDSI 306,000, acquired Open Form 4 filing 0001103021-21-000120
2021-11-12 P, Open-market purchase Biodelivery Sciences International IncBDSI 320,000, acquired Open Form 4 filing 0001103021-21-000114
2021-11-05 P, Open-market purchase Biodelivery Sciences International IncBDSI 894,566, acquired Open Form 4 filing 0001103021-21-000110
2021-05-13 P, Open-market purchase Biodelivery Sciences International IncBDSI 162,500, acquired Open Form 4 filing 0001103021-21-000046
2021-05-12 P, Open-market purchase Biodelivery Sciences International IncBDSI 324,000, acquired Open Form 4 filing 0001103021-21-000046
2021-05-11 P, Open-market purchase Biodelivery Sciences International IncBDSI 474,000, acquired Open Form 4 filing 0001103021-21-000046
2019-12-20 S, Open-market sale Biodelivery Sciences International IncBDSI 6,320,000, disposed Open Form 4 filing 0000919574-19-007768
2019-12-18 S, Open-market sale Biodelivery Sciences International IncBDSI 2 lines 6,485,000, disposed Open Form 4 filing 0000919574-19-007768
2019-11-18 S, Open-market sale Biodelivery Sciences International IncBDSI 2 lines 10,584,165, disposed Open Form 4 filing 0000919574-19-007363
2019-11-15 S, Open-market sale Biodelivery Sciences International IncBDSI 13,319,089, disposed Open Form 4 filing 0000919574-19-007363
2019-05-10 S, Open-market sale Biodelivery Sciences International IncBDSI 9,000,000, disposed Open Form 4 filing 0000919574-19-003369
2019-04-11 S, Open-market sale Biodelivery Sciences International IncBDSI 10,000,000, disposed Open Form 4 filing 0000919574-19-002943
2018-12-27 S, Open-market sale Novelion Therapeutics Inc.NVLN 3 lines 146,307, disposed Open Form 4 filing 0000919574-18-008175
2018-12-26 S, Open-market sale Novelion Therapeutics Inc.NVLN 7 lines 254,715, disposed Open Form 4 filing 0000919574-18-008175
2018-12-24 S, Open-market sale Novelion Therapeutics Inc.NVLN 392, disposed Open Form 4 filing 0000919574-18-008175
2018-05-24 S, Open-market sale Recro Pharma, Inc.REPH 5 lines 1,093,182, disposed Open Form 4 filing 0000919574-18-003940
2018-03-13 S, Open-market sale Recro Pharma, Inc.REPH 2,014,000, disposed Open Form 4 filing 0000919574-18-002503
2017-12-21 S, Open-market sale Recro Pharma, Inc.REPH 2 lines 500,240, disposed Open Form 4 filing 0000919574-17-008727
2017-12-20 S, Open-market sale Recro Pharma, Inc.REPH 250,000, disposed Open Form 4 filing 0000919574-17-008727
2017-12-13 S, Open-market sale Recro Pharma, Inc.REPH 2 lines 178,139, disposed Open Form 4 filing 0000919574-17-008600
2017-12-12 S, Open-market sale Recro Pharma, Inc.REPH 3 lines 740,989, disposed Open Form 4 filing 0000919574-17-008600
2017-12-05 S, Open-market sale Recro Pharma, Inc.REPH 1,000,000, disposed Open Form 4 filing 0000919574-17-008511
2017-12-01 S, Open-market sale Aratana Therapeutics, Inc.PETX 7 lines 3,059,350, disposed Open Form 4 filing 0000919574-17-008470
2017-11-30 S, Open-market sale Aratana Therapeutics, Inc.PETX 595,000, disposed Open Form 4 filing 0000919574-17-008470
2017-11-30 S, Open-market sale Aratana Therapeutics, Inc.PETX 297,500, disposed Open Form 4 filing 0000919574-17-008470
2017-11-30 S, Open-market sale Aratana Therapeutics, Inc.PETX 295,000, disposed Open Form 4 filing 0000919574-17-008470

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Broadfin Capital, LLC, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001511901

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.